Wealthspire Advisors, LLC Biogen Inc. Transaction History

Wealthspire Advisors, LLC

$9.93 Billion
Q4 2024

A detailed history of Wealthspire Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 1,712 shares of BIIB stock, worth $237,026. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,712

Previous 1,896 9.7%

Holding current value

$237,026

Previous $367,000 28.88%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	SELL	$146.47 - $191.55 $26,950 - $35,245	-184 Reduced 9.7%	1,712 $261,000
Q3 2024 Nov 13, 2024	SELL	$189.07 - $236.8 $23,444 - $29,363	-124 Reduced 6.14%	1,896 $367,000
Q2 2024 Aug 08, 2024	SELL	$190.52 - $236.72 $11,621 - $14,439	-61 Reduced 2.93%	2,020 $468,000
Q1 2024 May 06, 2024	SELL	$212.02 - $267.71 $63,393 - $80,045	-299 Reduced 12.56%	2,081 $448,000
Q4 2023 Feb 06, 2024	BUY	$222.59 - $267.94 $2,448 - $2,947	11 Added 0.46%	2,380 $615,000
Q3 2023 Nov 06, 2023	BUY	$253.3 - $285.89 $600,067 - $677,273	2,369 New	2,369 $608,000
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $235,778 - $286,476	934 New	934 $258,000
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $411,551 - $658,974	-1,589 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $58,308 - $68,311	240 Added 17.79%	1,589 $445,000
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $11,340 - $17,070	48 Added 3.69%	1,349 $330,000
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $23,564 - $27,208	89 Added 7.34%	1,301 $369,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $580,691 - $769,024	-2,245 Reduced 64.94%	1,212 $324,000
Q1 2020 May 12, 2020	BUY	$268.85 - $341.04 $659,757 - $836,912	2,454 Added 244.67%	3,457 $1.09 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $20,685 - $28,582	94 Added 10.34%	1,003 $298,000
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $197,652 - $221,686	909 New	909 $212,000
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $40,958 - $64,063	-189 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $52,636 - $66,669	189 New	189 $57,000

Others Institutions Holding BIIB

# of Institutions

996

Shares Held

129M

Call Options Held

1.37M

Put Options Held

1.51M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $19.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthspire Advisors, LLC with notifications on news.

Account

Wealthspire Advisors, LLC Biogen Inc. Transaction History